The oral BTK inhibitor race in RMS is now a two-horse affair, with fenebrutinib vying against Novartis' remibrutinib, already ...

Scientists are exploring smell tests as an early indicator of Alzheimer's risk, detecting brain changes years before memory ...

A routine blood marker tied to inflammation may reveal Alzheimer’s risk years in advance. Scientists found that higher neutrophil levels—part of the body’s first immune response—were linked to a ...

Ocugen and Roche have announced significant developments in precision medicine, with late-stage gene therapy programs advancing at Ocugen and positive Phase III results for Roche’s autoimmune and ...

New 2026 report finds CEZIH has reached real national scale, with 15 million annual eReferrals, 61 million ePrescriptions, 300,000 daily structured reports, and 1.5 million daily insurance checks driv ...

Patients experiencing higher levels of socioeconomic marginalization and without established family physicians were more ...

Researchers had previously discovered a population of immune cells within the brain that can act as accelerators and brakes ...

Nearly 1 in 4 patients with atrial fibrillation who experience an ischaemic stroke despite oral anticoagulation have ...

According to Arizton's latest research, the global teleradiology market is expected to reach USD 43.15 billion by 2031, ...

Merck is making a $1 billion investment in a deal with Google Cloud. Elsewhere, Roche pitched its case for a closely watched ...

Harness, the AI Software Delivery Platformtm company, today announced that it will bring together Harness's Software Delivery Knowledge Graph and Google Cloud's Developer Connect. The initiative gives ...

The MarketWatch News Department was not involved in the creation of this content. Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides ...